NCT04995900

Brief Summary

The aim of the study is to evaluate whether providing a targeted heart health education campaign to regions at high risk of heart attacks will improve ACS patient's symptom recognition and response. The intervention will be will be evaluated according to a cluster randomized, stepped wedged design. The clusters are eight local government areas (LGAs) in Victoria, Australia. The main primary outcome will be assessed in consecutive patients presenting to emergency departments from the six LGAs throughout the study period with an ED diagnoses of acute coronary syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 9, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

June 15, 2023

Status Verified

June 1, 2023

Enrollment Period

1.2 years

First QC Date

July 30, 2021

Last Update Submit

June 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ambulance use for ACS

    The proportion of ACS patients that present to ED by ambulance.

    16 months

Secondary Outcomes (21)

  • Median ACS patient delay time

    16 months

  • ACS patient delay time <60 minutes

    16 months

  • Median ACS patient prehospital delay time

    16 months

  • ACS patients prehospital delay times <120 minutes

    16 months

  • Awareness of own risk of heart attack

    0-2 months and 6-8 months

  • +16 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Intervention period with active Heart Matters education delivered

Other: Community education

Control

NO INTERVENTION

Control period with no Heart Matters education delivered.

Interventions

Heart Matters coordinators will deliver heart health education to the community using HM materials and Partner resources.

Also known as: Local campaign
Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Victorian LGAs

Melbourne, Please Select, 3004, Australia

Location

Related Publications (1)

  • Bray JE, Nehme Z, Finn JC, Kasza J, Clark RA, Stub D, Cadilhac DA, Buttery AK, Woods J, Kim J, Smith BJ, Smith K, Cartledge S, Beauchamp A, Dodge N, Walker T, Flemming-Judge E, Chow C, Stewart M, Cox N, van Gaal W, Nadurata V, Cameron P. A protocol for the Heart Matters stepped wedge cluster randomised trial: The effectiveness of heart attack education in regions at highest-risk. Resusc Plus. 2023 Jul 25;15:100431. doi: 10.1016/j.resplu.2023.100431. eCollection 2023 Sep.

MeSH Terms

Conditions

Acute Coronary SyndromeMyocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes are collected blinded to the study allocation.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: The stepped-wedge design is a uni-directional cross-over design - where the randomisation element is when the cluster crosses-over to the intervention following a control period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 30, 2021

First Posted

August 9, 2021

Study Start

February 1, 2022

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

June 15, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Access to data is restricted and is not available for sharing at the individual patient level.

Locations